bloodclots
Johnson & Johnson (NYSE:JNJ) is yet again making headlines after the pharmaceutical company was granted FDA approval for their new booster shot. Q3 2021 hedge fund letters, conferences and more Disclaimer: This is a satirical article. Johnson & Johnson Shares Soar On Its Booster Shot NewsJohnson & Johnson boasted about its lack of safety, citing “We out did ourselves with this one. Our new booster shot is now 79% more likely to cause blood clots, as to our previous jab which only had a roughly 32.5% chance at giving one a blood clot.” Johnson & Johnson shares soared on the good news. This post...
ValueWalk
The Johnson & Johnson is the hot topic of today’s news after the FDA & CDC recommended its vaccinations be paused following rare types of blood clots after vaccination reported in six different women as well as other side effects. While it is unclear if the J&J vaccine is directly responsible for these adverse reactions due to small sample size out of an ‘abundance of caution’ J&J is offering free baby powder as well as $15 gift cards to Dave & Busters to the women who suffered the blood clots. [soros] Q1 2021 hedge fund letters, conferences and more Sorry For Your Blood ClotsIn a handwritten ...
ValueWalk
Governments worldwide are already using various coronavirus vaccines to fight the pandemic, but the process is still on a trial and error stage; only now errors have real consequences as the doses are administered to the people. Q1 2021 hedge fund letters, conferences and more Johnson & Johnson Vaccine Paused Due To Patients Developing Blood ClotsOn Tuesday, the U.S. government’s scientists recommended a pause in administering the single-dose Johnson & Johnson vaccine due to reports that a handful of patients had developed serious blood clots after receiving the shot. The White House agreed on...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら